RECURRENT NEUROBLASTOMA

Clinical trials for RECURRENT NEUROBLASTOMA explained in plain language.

Never miss a new study

Get alerted when new RECURRENT NEUROBLASTOMA trials appear

Sign up with your email to follow new studies for RECURRENT NEUROBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Not yet finished but already full! 13 Completed 5

New hope for kids with tough neuroblastoma: drug combo trial launches

Disease control Not yet recruiting

This study tests whether adding iberdomide to standard chemoimmunotherapy is safe and works better for children and young adults (ages 1–30) with neuroblastoma that has come back or not responded to prior treatment. About 76 participants will receive either the standard treatment…

Matched conditions: RECURRENT NEUROBLASTOMA

Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated May 04, 2026 16:22 UTC

RECURRENT NEUROBLASTOMA

Get alerted when new RECURRENT NEUROBLASTOMA trials appear

New hope for kids with tough neuroblastoma: drug combo trial launches